Longitudinal Study of Neurogenetic Disorders

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorColumbia University

About this trial

The purpose of this study is to analyze patterns in individuals with hnRNP (and other) genetic variants, including their neurological comorbidities, other medical problems and any treatment. The investigators will maintain an ongoing database of medical data that is otherwise being collected for routine medical care. The investigators will also collect data prospectively in the form of questionnaires, neuropsychological assessments, motor assessments, and electroencephalography to examine the landscape of deleterious variants in these genes.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Individuals must have had whole genome/exome sequencing and have a confirmed variant in any gene.

Disqualifiers

Subjects who cannot provide genetic confirmation of a predicted deleterious variant in any gene.

Trial population

Individuals who have already undergone genetic testing and carry a variant in any gene. Individuals will often present with neurological abnormalities, although the absence of symptoms is not exclusion criterion for the study. International subjects are welcome to enroll if eligibility criteria is met.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

1,000 Participants
are grouped into 2 trial groups
Group A: Variant in a hnRNP gene
Group B: Variant in other gene

Trial outcomes

Primary outcomes

1

Medical abnormalities associated with genetic variants

Gene variants are known to result in a variety of clinical phenotypes. The study is intended to accrue data from medical records that document the range of neurological phenotypes and explore their incidence and frequency across genetic cohorts.

Time frame
5 years
2

Education-based impairments associated with genetic variants

The study seeks to collect records from the schools attended by participants; including: Individualized Education Programs (IEPs) and school records. We intend to use these records, in tandem with medical records, to explore meaningful statistical and clinical relationships in the phenotypes expressed by the population of the study.

Time frame
5 years
3

Repetitive Behavior

Correlations (r) between mutant allele (obtained from retrospective data) and repetitive behavior (measured by the Repetitive Behavior Scale - Revised; RBS-R)

Time frame
5 years
4

Sleep Habits

Correlations (r) between mutant allele (obtained from retrospective data) and sleep habits (measured by The Children's Sleep Habits Questionnaire; CSHQ)

Time frame
5 years

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Columbia University

Lead sponsor

Simons Foundation

Collaborator

New York University

Collaborator

Hackensack Meridian Health

Collaborator

Universitätsklinikum Hamburg-Eppendorf

Collaborator